Zobrazeno 1 - 10
of 179
pro vyhledávání: '"Mader, JK"'
Autor:
Bally, L, Thabit, H, Ruan, Y, Mader, JK, Kojzar, H, Dellweg, S, Benesch, C, Hartnell, S, Leelarathna, L, Wilinska, ME, Evans, ML, Arnolds, S, Pieber, TR, Hovorka, R
Publikováno v:
Bally, L, Thabit, H, Ruan, Y, Mader, J K, Kojzar, H, Dellweg, S, Benesch, C, Hartnell, S, Leelarathna, L, Wilinska, M E, Evans, M L, Arnolds, S, Pieber, T R & Hovorka, R 2017, ' Bolusing frequency and amount impacts glucose control during hybrid closed-loop ', Diabetic Medicine . https://doi.org/10.1111/dme.13436
Bally, L; Thabit, H; Ruan, Y; Mader, J K; Kojzar, H; Dellweg, S; Benesch, C; Hartnell, S; Leelarathna, L; Wilinska, M E; Evans, M L; Arnolds, S; Pieber, T R; Hovorka, R (2018). Bolusing frequency and amount impacts glucose control during hybrid closed-loop. Diabetic medicine, 35(3), pp. 347-351. Wiley 10.1111/dme.13436
Bally, L; Thabit, H; Ruan, Y; Mader, J K; Kojzar, H; Dellweg, S; Benesch, C; Hartnell, S; Leelarathna, L; Wilinska, M E; Evans, M L; Arnolds, S; Pieber, T R; Hovorka, R (2018). Bolusing frequency and amount impacts glucose control during hybrid closed-loop. Diabetic medicine, 35(3), pp. 347-351. Wiley 10.1111/dme.13436
Aim: To compare bolus insulin delivery patterns during closed-loop home studies in adults with suboptimally [HbA1c 58-86 mmol/mol (7.5%-10%)] and well-controlled [58 mmol/mol (< 7.5%)] Type 1 diabetes. Methods: Retrospective analysis of daytime and n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6a3e516275ae6db7ff01a8edd40a6c8
Autor:
Ruan, Y, Thabit, H, Leelarathna, L, Hartnell, S, Wilinska, ME, Tauschmann, M, Dellweg, S, Benesch, C, Mader, JK, Holzer, M, Kojzar, H, Evans, ML, Pieber, TR, Arnolds, S, Hovorka, R, Consortium, On Behalf Of AP@Home
We aimed to evaluate the relationship between insulin pharmacodynamics and glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy. We retrospectively analysed data from a multicentre randomized control trial involvin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bd2684affedebd5d5da3f10bd98f587
https://www.repository.cam.ac.uk/handle/1810/265187
https://www.repository.cam.ac.uk/handle/1810/265187
Autor:
Revital, Nimri, Nathan, Murray, Alexander, Ochs, Jordan, E Pinsker, Eyal, Dassau, Pinsker, Je, Lee, Jb, Dassau, E, Seborg, De, Bradley, Pk, Gondhalekar, R, Bevier, Wc, Huyett, L, Zisser, Hc, FJ Doyle III, DEL FAVERO, Simone, Boscari, F, Messori, M, Rabbone, I, Bonfanti, R, Sabbion, A, Iafusco, D, Schiaffini, R, Visentin, R, Calore, R, Moncada, Yl, Galasso, S, Galderisi, A, Vallone, V, DI PALMA, Federico, Losiouk, E, Lanzola, G, Tinti, D, Rigamonti, A, Marigliano, M, Zanfardino, A, Rapini, N, Avogaro, A, Chernavvsky, D, Magni, L, Cobelli, C, Bruttomesso, D, Sherr, Jl, Patel, Ns, Michaud, Ci, Palau-Collazo, Mm, MA Van Name, Tamborlane, Wv, Cengiz, E, Carria, Lr, Tichy, Em, Weinzimer, Sa, Renard, E, Farret, A, Kropff, J, Place, J, Toffanin, C, Magni, P, Keith-Hynes, P, Kovatchev, B, Devries, Jh, AP@ home Consortium, Gingras, V, Haidar, A, Messier, V, Legault, L, Ladouceur, M, Rabasa-Lhoret, R, Tt, Ly, Maahs, Dm, Roy, A, Grosman, B, Cantwell, M, Kurtz, N, Carria, L, Messer, L, R von Eyben, Buckingham, Ba, Ruan, Y, Thabit, H, Leelarathna, L, Hartnell, S, Willinska, Me, Dellweg, S, Benesch, C, Mader, Jk, Holzer, M, Kojzar, H, Evans, Ml, Pieber, Tr, Arnolds, S, Hovorka, R, Tauschmann, M, Allen, Jm, Wilinska, Me, Stewart, Z, Cheng, P, Kollman, C, Acerini, Cl, Dunger, Db, Monaro, M, Kovatchev, Bp, AP@ home consortium1, Heinemann, L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3657::9bfa7f7dfa9c20fe9a77e780c1c5a62d
http://hdl.handle.net/11577/3266854
http://hdl.handle.net/11577/3266854
Autor:
Luijf, Ym, Mader, Jk, Doll, W, Pieber, T, Farret, A, Place, J, Renard, E, Bruttomesso, D, Filippi, A, Avogaro, Angelo, Arnolds, S, Benesch, C, Heinemann, L, Devries, Jh, Ap@home, Consortium
Publikováno v:
Diabetes technology & therapeutics, 15(8), 722-727. Mary Ann Liebert Inc.
Diabetes Technology & Therapeutics
Diabetes Technology & Therapeutics
This study assessed the accuracy and reliability of three continuous glucose monitoring (CGM) systems. We studied the Animas® (West Chester, PA) Vibe™ with Dexcom® (San Diego, CA) G4™ version A sensor (G4A), the Abbott Diabetes Care (Alameda, C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c4c8fc860a1cdb03d66f50becd9ec38
http://hdl.handle.net/11577/2836957
http://hdl.handle.net/11577/2836957
Autor:
Mader JK (AUTHOR), Feichtner F (AUTHOR), Bock G (AUTHOR), Köhler G (AUTHOR), Schaller R (AUTHOR), Plank J (AUTHOR), Pieber TR (AUTHOR), Ellmerer M (AUTHOR)
Publikováno v:
Diabetes Research & Clinical Practice. Jul2012, Vol. 97 Issue 1, p112-118. 7p.
Autor:
Mader JK, Weinhandl H, Köhler G, Plank J, Bock G, Korsatko S, Ratzer M, Ikeoka D, Köhler H, Pieber TR, Ellmerer M
Publikováno v:
Diabetic Medicine; Mar2010, Vol. 27 Issue 3, p332-338, 7p
Autor:
Mader, JK, Korsatko, S, Ikeoka, D, Plank, J, Bodenlenz, M, Suppan, M, Sinner, F, Smolle, KH, Pieber, TR, Ellmerer, M
Publikováno v:
Critical Care; March 2007, Vol. 11 Issue: Supplement 2 p1-201, 201p
Publikováno v:
Critical Care; March 2010, Vol. 14 Issue: Supplement 1 p1-1, 1p